{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T13:08:02Z","timestamp":1717592882268},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","trasci.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.transci.2016.11.004","type":"journal-article","created":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T17:39:04Z","timestamp":1480527544000},"page":"179-189","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Quantifying in vivo murine antigen-specific T cell responses without requirement for prior knowledge of antigen identity"],"prefix":"10.1016","volume":"56","author":[{"given":"Nour","family":"Kibbi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enping","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harib","family":"Ezaldein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Hanlon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek","family":"Fahmy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Edelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2016.11.004_bib0005","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1089\/cbr.2011.0973","article-title":"Features associated with survival in metastatic melanoma patients treated with patient-specific dendritic cell vaccines","volume":"26","author":"Dillman","year":"2011","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.transci.2016.11.004_bib0010","doi-asserted-by":"crossref","first-page":"8525","DOI":"10.1200\/jco.2007.25.18_suppl.8525","article-title":"Kinetics of response to ipilimumab (MDX-010) in patients with stage III\/IV melanoma [abstract]","volume":"25","author":"Hamid","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2016.11.004_bib0015","first-page":"5950","article-title":"Phase I\/II study of ipilimumab for patients with metastatic melanoma","volume":"36","author":"Weber","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2016.11.004_bib0020","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/nbt.2000","article-title":"A methodological framework to enhance the clinical success of cancer immunotherapy","volume":"29","author":"Hoos","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.transci.2016.11.004_bib0025","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1200\/jco.2009.27.15_suppl.3020","article-title":"Association of peripheral blood absolute lymphocyte count (ALC) and clinical activity in patients (pts) with advanced melanoma treated with ipilimumab [abstract]","volume":"27","author":"Berman","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2016.11.004_bib0030","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1200\/jco.2010.28.15_suppl.2555","article-title":"CTLA-4 blockade with ipilimumab increases peripheral CD8+ T cells: correlation with clinical outcomes. [abstract]","volume":"28","author":"Yang","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2016.11.004_bib0035","doi-asserted-by":"crossref","first-page":"9008","DOI":"10.1200\/jco.2009.27.15_suppl.9008","article-title":"Association of baseline and on-study tumor biopsy markers with clinical activity in patients with advanced melanoma treated with ipilimumab [abstract]","volume":"27","author":"Hamid","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2016.11.004_bib0040","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1158\/1078-0432.CCR-08-2424","article-title":"Melan-A-specific cytotoxic T cells are associated with tumor regression and autoimmunity following treatment with anti-CTLA-4","volume":"15","author":"Klein","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.transci.2016.11.004_bib0045","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1479-5876-6-22","article-title":"Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanoma","volume":"6","author":"Comin-Anduix","year":"2008","journal-title":"J Transl Med"},{"key":"10.1016\/j.transci.2016.11.004_bib0050","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.coi.2008.04.004","article-title":"Calcium signaling in lymphocytes","volume":"3","author":"Oh-hora","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.transci.2016.11.004_bib0055","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1021\/nl801693k","article-title":"Label-free electronic detection of the antigen-specific T-cell immune response","volume":"8","author":"Stern","year":"2008","journal-title":"Nanoletters"},{"key":"10.1016\/j.transci.2016.11.004_bib0060","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.cell.2015.08.012","article-title":"Phosphoenolpyruvate is a metabolic checkpoint of anti-tumor T cell responses","volume":"162","author":"Ho","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.transci.2016.11.004_bib0065","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0022-1759(89)90284-6","article-title":"Measurement of cytoplasmic calcium in lymphocytes during flow cytometry","volume":"120","author":"Griffoen","year":"1989","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.transci.2016.11.004_bib0070","doi-asserted-by":"publisher","first-page":"e10024","DOI":"10.7554\/eLife.10024","article-title":"Near-infrared photoactivatable control of Ca(2+) signaling and optogenetic immunomodulation","volume":"4","author":"He","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.transci.2016.11.004_bib0075","doi-asserted-by":"publisher","first-page":"4965","DOI":"10.4049\/jimmunol.1203224","article-title":"Fine-tuning of regulatory T cell function: the role of calcium signals and naive regulatory T cells for regulatory T cell deficiency in multiple sclerosis","volume":"190","author":"Schwarz","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.transci.2016.11.004_bib0080","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1073>3.0.CO;2-R","article-title":"Induction of human tumor-loaded dendritic cells","volume":"91","author":"Berger","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.transci.2016.11.004_bib0085","first-page":"351","article-title":"Methods in molecular biology","volume":"vol. 960","year":"2016"},{"key":"10.1016\/j.transci.2016.11.004_bib0090","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1016\/j.vaccine.2009.03.034","article-title":"Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy","volume":"27","author":"Demento","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.transci.2016.11.004_bib0095","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/ni.3411","article-title":"Spontaneous partial loss of the OT-I transgene","volume":"17","author":"Pritchard","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.transci.2016.11.004_bib0100","doi-asserted-by":"publisher","first-page":"23068","DOI":"10.1074\/jbc.M112.357673","article-title":"Interplay between T cell receptor binding kinetics and the level of cognate peptide presented by major histocompatibility complexes governs CD8+T cell responsiveness","volume":"287","author":"Irving","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.transci.2016.11.004_bib0105","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ymeth.2008.09.025","article-title":"Chemical calcium indicators","volume":"46","author":"Paredes","year":"2008","journal-title":"Methods"},{"key":"10.1016\/j.transci.2016.11.004_bib0110","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.immuni.2006.05.015","article-title":"Altered peptide ligands induce delayed CD8-T cell receptor interaction \u2013 a role for CD8 in distinguishing antigen quality","volume":"25","author":"Yachi","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.transci.2016.11.004_bib0115","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nature09863","article-title":"Cross-dressed dendritic cells drive memory CD8+ T-cell activation after viral infection","volume":"471","author":"Wakim","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.transci.2016.11.004_bib0120","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1084\/jem.20131271","article-title":"Memory CD8+ T cells exhibit increased antigen threshold requirements for recall proliferation","volume":"211","author":"Mehlhop-Williams","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.transci.2016.11.004_bib0125","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.transci.2016.06.001","article-title":"Induction of anti-tumor CD8 T cell responses by experimental ECP-induced human dendritic antigen presenting cells","volume":"55","author":"Kibbi","year":"2016","journal-title":"Transfus Apheresis Sci"},{"key":"10.1016\/j.transci.2016.11.004_bib0130","doi-asserted-by":"publisher","first-page":"7577","DOI":"10.4049\/jimmunol.179.11.7577","article-title":"Differential development of murine dendritic cells by GM-CSF versus Flt3 ligand has implications for inflammation and trafficking","volume":"179","author":"Xu","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.transci.2016.11.004_bib0135","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1046\/j.1365-2249.1998.00599.x","article-title":"Tumour-specific cytotoxic T lymphocyte activity in Th2-type Sezary syndrome: its enhancement by interferon-gamma and IL-12 and fluctuations in association with disease activity","volume":"112","author":"Seo","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.transci.2016.11.004_bib0140","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/01.tp.0000267785.52567.9c","article-title":"Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease","volume":"84","author":"Biagi","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.transci.2016.11.004_bib0145","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.immuni.2007.04.013","article-title":"Initial T cell receptor transgenic cell precursor frequency dictates critical aspects of the CD8+ T cell responses to infection","volume":"26","author":"Badovinac","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.transci.2016.11.004_bib0150","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.4049\/jimmunol.173.5.2923","article-title":"Cutting edge: regulation of CD8+ T cell effector population size","volume":"173","author":"Kemp","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.transci.2016.11.004_bib0155","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/sj.icb.7100076","article-title":"Optimization of TCR transgenic T cells for in vivo tracking of immune responses","volume":"85","author":"Stock","year":"2007","journal-title":"Immunol Cell Biol"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050216301719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050216301719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T16:43:58Z","timestamp":1601225038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050216301719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1473050216301719"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2016.11.004","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantifying in vivo murine antigen-specific T cell responses without requirement for prior knowledge of antigen identity","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2016.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}